Van ECK Associates Corp bought a new position in Plexus Corp. (NASDAQ:PLXS – Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 22,100 shares of the technology company’s stock, valued at approximately $6,645,000. Van ECK Associates Corp owned about 0.08% of Plexus at the end of the most recent quarter.
Other large investors also recently made changes to their positions in the company. BlackRock Inc. bought a new stake in shares of Plexus during the second quarter valued at approximately $1,311,631,000. Bank of America Corp DE bought a new position in Plexus in the 2nd quarter worth approximately $60,281,000. Victory Capital Management Inc. increased its position in Plexus by 130.0% in the 4th quarter. Victory Capital Management Inc. now owns 349,057 shares of the technology company’s stock valued at $51,311,000 after acquiring an additional 197,283 shares during the period. Bank of New York Mellon Corp bought a new stake in Plexus during the 2nd quarter valued at $55,525,000. Finally, Emerald Advisers LLC acquired a new position in Plexus during the 1st quarter worth $33,729,000. Institutional investors and hedge funds own 94.45% of the company’s stock.
Plexus Trading Up 0.3%
Plexus stock opened at $239.29 on Thursday. The firm has a market cap of $6.40 billion, a price-to-earnings ratio of 35.29 and a beta of 0.89. Plexus Corp. has a 1 year low of $132.03 and a 1 year high of $307.06. The firm’s 50 day moving average price is $260.39 and its two-hundred day moving average price is $244.98. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.72 and a current ratio of 1.49.
Analysts Set New Price Targets
PLXS has been the topic of a number of research analyst reports. Stifel Nicolaus raised their price target on Plexus from $280.00 to $330.00 and gave the company a “buy” rating in a report on Monday, June 22nd. Sidoti upgraded shares of Plexus from a “neutral” rating to a “buy” rating and set a $308.00 target price for the company in a research report on Friday, July 31st. Zacks Research raised shares of Plexus from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 11th. Needham & Company LLC restated a “buy” rating and set a $310.00 price target on shares of Plexus in a research report on Friday, August 14th. Finally, Weiss Ratings lowered shares of Plexus from a “buy (b)” rating to a “buy (b-)” rating in a research note on Tuesday, August 11th. One research analyst has rated the stock with a Strong Buy rating and six have assigned a Buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and an average target price of $273.00.
Get Our Latest Stock Analysis on Plexus
Insider Buying and Selling
In related news, Director Karen Marie Rapp sold 500 shares of the stock in a transaction on Monday, August 31st. The stock was sold at an average price of $240.87, for a total value of $120,435.00. Following the completion of the transaction, the director owned 7,535 shares in the company, valued at $1,814,955.45. This trade represents a 6.22% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Todd P. Kelsey sold 1,500 shares of Plexus stock in a transaction dated Wednesday, August 19th. The stock was sold at an average price of $250.98, for a total value of $376,470.00. Following the completion of the transaction, the chief executive officer directly owned 65,888 shares in the company, valued at $16,536,570.24. This represents a 2.23% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 8,010 shares of company stock worth $2,178,182. Company insiders own 1.78% of the company’s stock.
Plexus Profile
Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.
Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.
See Also
- Five stocks we like better than Plexus
- Striking Oil: How the U.S. Play for Venezuela Fuels Supermajors
- J.M. Smucker Stock’s Rally Has More Than Tariffs Behind It
- Wendy’s Rally Fades After Trian Steps Back: Was It Ever Real?
- GitLab’s Earnings Beat Just Gave Software Bulls a New SaaSpocalypse Test
Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXS – Free Report).
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
